Liberum Capital Reiterates “Buy” Rating for Tate & Lyle (TATE)

Tate & Lyle (LON:TATE)‘s stock had its “buy” rating restated by analysts at Liberum Capital in a research report issued to clients and investors on Monday. They currently have a GBX 850 ($11.53) target price on the stock. Liberum Capital’s price target would indicate a potential upside of 31.78% from the stock’s current price.

TATE has been the topic of several other reports. Jefferies Group upgraded shares of Tate & Lyle to a “buy” rating and decreased their price target for the stock from GBX 800 ($10.85) to GBX 750 ($10.17) in a research report on Monday, October 23rd. Investec restated a “buy” rating and set a GBX 735 ($9.97) price objective on shares of Tate & Lyle in a research report on Monday. Deutsche Bank restated a “hold” rating and set a GBX 725 ($9.83) price objective on shares of Tate & Lyle in a research report on Friday, November 3rd. Shore Capital Group restated a “hold” rating on shares of Tate & Lyle in a research report on Thursday, November 2nd. Finally, Berenberg Bank restated a “hold” rating and set a GBX 730 ($9.90) price objective on shares of Tate & Lyle in a research report on Thursday, November 2nd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. Tate & Lyle has an average rating of “Hold” and a consensus price target of GBX 742.67 ($10.07).

Shares of Tate & Lyle (LON TATE) traded down GBX 1.20 ($0.02) during trading on Monday, reaching GBX 645 ($8.75). 1,420,977 shares of the company were exchanged, compared to its average volume of 1,660,000. The company has a market capitalization of $3,000.00 and a P/E ratio of 1,216.98. Tate & Lyle has a 12 month low of GBX 622 ($8.44) and a 12 month high of GBX 796.50 ($10.80).

TRADEMARK VIOLATION NOTICE: This story was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.americanbankingnews.com/2018/01/29/liberum-capital-reiterates-buy-rating-for-tate-lyle-tate.html.

About Tate & Lyle

Tate & Lyle PLC is a provider of ingredients and solutions to the food, beverage and other industries. The Company’s segments include Speciality Food Ingredients and Bulk Ingredients. The Speciality Food Ingredients segment’s product categories include dairy, beverage, bakery and convenience. The Bulk Ingredients segment’s product lines include bulk sweeteners for food and beverage customers, and industrial starches for paper and construction industries.

Analyst Recommendations for Tate & Lyle (LON:TATE)

Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply